Skip to main content

OptimizeRx Corp

OPRX
Exchange
Nasdaq
Industry
Services-Business Services, NEC
SEC CIK
0001448431

No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding OptimizeRx Corp changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of OPRX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders95298+5
Shares13.1M686.9K12.5M+108.7K (+0.9%)
Value$101.8M$5.34M$178.8M+$82.3M (+85.3%)

2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held OptimizeRx Corp at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to OPRX in Q4 2023
InstitutionSharesValue% of portfolio
Divisadero Street Capital Management, LP949,550$13.6M3.07%
Samjo Management, LLC410,900$5.88M2.08%
Millrace Asset Group, Inc.133,936$1.92M1.90%
Renaissance Technologies LLC92,345$1.32M0.00%
Point72 Asset Management, L.P.77,520$1.11M0.00%
American Century Companies Inc44,895$642.4K0.00%
Acadian Asset Management LLC44,869$641.0K0.00%
Occudo Quantitative Strategies LP19,967$285.7K0.04%
Simplex Trading, LLC18,531$265.0K0.01%
Hillsdale Investment Management Inc.15,700$224.7K0.02%
Algert Global LLC12,630$180.7K0.01%
Verition Fund Management LLC11,726$167.8K0.00%
Corton Capital Inc.10,663$152.6K0.05%
Cubist Systematic Strategies, LLC8,179$117.0K0.00%
Cetera Trust Company, N.A5,400$77.3K0.05%
Northwestern Mutual Wealth Management Co3,109$44.5K0.00%
AJOVista, LLC1,697$24.3K0.03%
Point72 Asia (Singapore) Pte. Ltd.618$8.85K0.00%
Householder Group Estate & Retirement Specialist, LLC70$1.00K0.00%
ICA Group Wealth Management, LLC50$7160.00%
Russell Investments Group, Ltd.31$4440.00%

Sold out (16)

Institutions that held OptimizeRx Corp at the end of Q3 2023 and filed for Q4 2023 without it.

Not filed for Q4 2023 yet (2)

Institutions that held OptimizeRx Corp at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OPRX in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Jacob Asset Management of New York LLC370,330$2.88M
Samjo Capital LLC316,600$2.46M